Abstract
Crop breeding, through methods like biofortification, plays a crucial role in increasing agricultural yields, contributing to a stable and healthy food supply by boosting the micronutrient content of staples, which is pivotal for combating chronic and hidden hunger, especially in rural areas. This shift towards improved nutrition can be sustainably integrated into regular diets, marking a significant stride in public health. The burden of hunger and its consequences on health are increasingly quantified using the Disability-Adjusted Life Years (DALYs) approach, which merges years of life lost and years lived with disability, offering a comprehensive view of health impacts and aiding in resource allocation despite its complexity and subjective nature. A practical formula for quantifying the health impact of biofortification was introduced by Stein et al. (2005) and Zimmermann and Qaim (2004). This entails calculating the efficacy or relative reduction in hunger burden based on the current and post-intervention nutrient intake against the recommended dietary allowances. As data on consumption and recommended intake levels are variable and not readily available, this paper proposes relying on relative estimates to bridge the data gaps and uncertainties, thus streamlining the quantification of crop breeding’s impact on diets and overall health.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We would like to thank all funders who supported this research through their contributions to the CGIAR Trust Fund: http://www.cgiar.org/funders and the CGIAR Initiative on Market Intelligence.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.